Cultured muscle produced by mechanical conditioning

Patent metadata

Field	Value
Publication number	US-9506025-B2
Application number	US-42938509-A
Country	US
Kind code	B2
Filing date	Apr 24, 2009
Priority date	Apr 15, 2005
Publication date	Nov 29, 2016
Grant date	Nov 29, 2016

Abstract

A method of producing organized skeletal muscle tissue from precursor muscle cells in vitro comprises: (a) providing precursor muscle cells on a support in a tissue media; then (b) cyclically stretching and relaxing the support at least twice along a first axis during a first time period; and then (c) optionally but preferably maintaining the support in a substantially static position during a second time period; and then (d) repeating steps (b) and (c) for a number of times sufficient to enhance the functionality of the tissue formed on the support and/or produce organized skeletal muscle tissue on the solid support from the precursor muscle cells.

First claim

That which is claimed is:

1. Cultured organized skeletal muscle tissue produced by a process comprising:
(a) providing a decellularized tissue support in a tissue media in a bioreactor, said support comprising precursor muscle cells; then
(b) cyclically stretching and relaxing said support at least twice along a first axis during a first time period; and then
(c) maintaining said support in a substantially static position during a second time period; and then
(d) repeating steps (b) and (c) for a number of times sufficient to produce said cultured organized skeletal muscle tissue on said support from said precursor muscle cells, wherein repeating steps (b) and (c) is carried out for a time of up to two weeks and results in the cultured organized skeletal muscle tissue having unidirectional orientation, and
wherein said cultured organized skeletal muscle tissue is further characterized by enhancing cellular organization, contractile function and tissue formation when implanted in vivo.

2. The cultured organized skeletal muscle tissue of claim 1 , wherein said cyclically stretching and relaxing is carried out at least three times during said first time period.

3. The cultured organized skeletal muscle tissue of claim 1 , wherein said stretching comprises extending said support to a dimension at least 5% greater in length than said static position.

4. The cultured organized skeletal muscle tissue of claim 1 , wherein said first time period is from 2 to 30 minutes in duration.

5. The cultured organized skeletal muscle tissue of claim 1 , wherein said second time period is from 10 to 100 minutes in duration.

6. The cultured organized skeletal muscle tissue of claim 1 , wherein said repeating of steps (b) and (c) is carried out for a time of five days to one week.

7. The cultured organized skeletal muscle tissue of claim 1 , wherein said precursor muscle cells are human cells.

8. The cultured organized skeletal muscle tissue of claim 1 , wherein said cultured organized skeletal muscle tissue is suturable and is 1 to 50 cm in length.

9. The cultured organized skeletal muscle tissue of claim 1 , wherein said cultured organized skeletal muscle tissue contracts in response to electrical stimulation four weeks after in vivo implantation.

10. The cultured organized skeletal muscle tissue of claim 1 , wherein said decellularized tissue support comprises decellularized smooth muscle or decellularized skeletal muscle.

11. The cultured organized skeletal muscle tissue of claim 10 , wherein said decellularized tissue support comprises decellularized mammalian bladder.

12. An implantable skeletal muscle construct produced by a process comprising:
(a) providing a suturable support in a tissue media in a bioreactor, wherein said suturable support comprises mammalian precursor muscle cells, and wherein said suturable support comprises decellularized smooth muscle or decellularized skeletal muscle; then
(b) cyclically stretching and relaxing said suturable support at least twice along a first axis during a time period of from 2 to 30 minutes in duration; and then
(c) maintaining said suturable support in a substantially static position for a time period of from 10 to 100 minutes in duration; and then
(d) repeating steps (b) and (c) for a number of times sufficient to produce said implantable skeletal muscle construct on said suturable support from said precursor muscle cells, wherein repeating steps (b) and (c) is carried out for a time of up to two weeks and results in the implantable skeletal muscle construct having unidirectional orientation, and
wherein said implantable skeletal muscle construct is further characterized by enhancing cellular organization, contractile function and tissue formation when implanted in vivo.

13. The implantable skeletal muscle construct of claim 12 , wherein said suturable support comprises decellularized mammalian bladder.

14. The implantable skeletal muscle construct of claim 12 , wherein said suturable support comprises decellularized porcine bladder.

15. The implantable skeletal muscle construct of claim 12 , wherein said precursor muscle cells are human cells.

Assignees

• Yoo James
• Stitzel Joel
• Atala Anthony
• Christ George
• Univ Wake Forest Health Sciences

Inventors

• Yoo James
• Stitzel Joel
• Atala Anthony
• Christ George

Classifications

• C12M21/08

  for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00) · CPC title

• C12N5/0658

  Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts · CPC title

• A61L27/3691

  characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation · CPC title

• A61L27/3683

  subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment · CPC title

• A61F2002/0894

  Muscles · CPC title